These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 2530945

  • 1. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM, Carr AA, Nelson EB, Winer N, Velasquez MT, Gonasun LM.
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of isradipine in hypertension.
    Shepherd AM, Carr AA, Davidov M, Hamilton J, Schnaper H, Velasquez M, Brockway B, Prisant LM, Hamilton B, Gonasun L.
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G, Cuspidi C, Sampieri L, Ambrosioni E, Malini PL, Pessina A, Semplicini A, Cinotti G, Morabito S, Rappelli A.
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [Abstract] [Full Text] [Related]

  • 5. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
    Fernandez PG, Kim BK, Galway AB.
    Pharmatherapeutica; 1984 Feb; 3(8):505-14. PubMed ID: 6322207
    [Abstract] [Full Text] [Related]

  • 6. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 7. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 10. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 11. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD, Mullane JF.
    Clin Ther; 1982 Sep; 4(6):497-509. PubMed ID: 7046937
    [Abstract] [Full Text] [Related]

  • 12. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
    Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
    [Abstract] [Full Text] [Related]

  • 13. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A, Cristal N.
    J Cardiovasc Pharmacol; 1990 Feb 12; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [Abstract] [Full Text] [Related]

  • 14. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 12; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 12; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 16. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993 Mar 12; 15(2):364-73. PubMed ID: 8519044
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial.
    Maroko PR, McDevitt JT, Fox MJ, Silber SA, Young MD, Beg M, Rockhold FW, Free SM, Herron JR, Gray JM.
    Clin Ther; 1989 Mar 12; 11(1):94-119. PubMed ID: 2655909
    [Abstract] [Full Text] [Related]

  • 18. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.
    Arch Intern Med; 1981 Mar 12; 141(4):482-6. PubMed ID: 7011237
    [Abstract] [Full Text] [Related]

  • 19. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R, Sever PS, Di Perri T, Redon J, Laurandin I, Brault Y, Chastang C, Guez D.
    J Hypertens; 1995 Dec 12; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM.
    J Cardiovasc Pharmacol; 1988 Dec 12; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.